Atorvastatin Calcium NDC 55111-123

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-123Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0123Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-123-05	55111012305	500 TABLET in 1 BOTTLE (55111-123-05)Marketed from Jul 17, 2012
55111-123-10	55111012310	1000 TABLET in 1 BOTTLE (55111-123-10)Marketed from Jul 17, 2012
55111-123-30	55111012330	30 TABLET in 1 BOTTLE (55111-123-30)Marketed from Jul 17, 2012
55111-123-60	55111012360	60 TABLET in 1 BOTTLE (55111-123-60)Marketed from Jul 17, 2012
55111-123-90	55111012390	90 TABLET in 1 BOTTLE (55111-123-90)Marketed from Jul 17, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atorvastatin Calcium
Generic name (nonproprietary): atorvastatin calcium
Active ingredients: Atorvastatin calcium trihydrate — 40 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Dr. Reddy's Laboratories Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091650
Marketing start: Jul 17, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)
Identifiers: Product ID 55111-123_36e09eff-3948-2638-b633-d5ec2bc03d2aSPL ID 36e09eff-3948-2638-b633-d5ec2bc03d2aSPL set ID 901550e6-22be-68c9-eb86-f85a9c9dd998RxCUI 617310, 617311, 617312UNII 48A5M73Z4QUPC 0355111123903
Pharmacologic class: HMG-CoA Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111012305 followed by a unit qualifier and the quantity

Package 55111-0123-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 20, 2021.

Indications (excerpt from the label)

Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. In patients with CHD or multiple risk factors for CHD, atorvastatin calcium tablets can be started simultaneously with diet. Atorvastatin calcium tablet is an HMG-CoA reductase inhibitor indicated as an adjunct therapy to diet to: Reduce the risk of MI, stroke, revascularization procedures, and angin…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091650

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091650
Product	Strength	Form · route	Labeler	Product NDC
Atorvastatin Calcium	Atorvastatin calcium trihydrate 10 mg/1	TabletOral	Dr. Reddy's Laboratories Limited	55111-121
Atorvastatin Calcium	Atorvastatin calcium trihydrate 20 mg/1	TabletOral	Dr. Reddy's Laboratories Limited	55111-122